IOTROLAN - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for iotrolan and what is the scope of freedom to operate?
Iotrolan
is the generic ingredient in two branded drugs marketed by Bayer Hlthcare and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for IOTROLAN
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 38 |
Patent Applications: | 1,941 |
DailyMed Link: | IOTROLAN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for IOTROLAN
US Patents and Regulatory Information for IOTROLAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Hlthcare | OSMOVIST 190 | iotrolan | INJECTABLE;INTRATHECAL | 019580-001 | Dec 7, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bayer Hlthcare | OSMOVIST 240 | iotrolan | INJECTABLE;INTRATHECAL | 019580-002 | Dec 7, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |